The 2026 season is calling will you answer?
Instruct patients to inform their healthcare provider that they are taking XIGDUO XR prior to any surgical or radiological procedure, as temporary discontinuation of XIGDUO XR may be required until renal function has been confirmed to be normal [see WARNINGS AND PRECAUTIONS ]
While these reports do not establish causation, they underscore the challenges associated with widespread use of a medication that remains under investigation
Additionally, more large-scale, long-term human studies are needed to fully establish the comparative effectiveness of S-acetyl L-glutathione versus regular glutathione across various health outcomes
In comparison, an emerging treatment with potential therapeutic application, in the form of a pentadecapeptide known as BPC 157 (body protection compound), appears to be somewhat unrestricted by the limitations seen in previous therapies
further large-scale, multicenter, population-based studies are required to corroborate these findings